First COVID-19 case of delta variant reported in the area – WDSU New Orleans

First COVID-19 case of delta version reported in the area
LSU Health New Orleans School of Medicine has reportedly identified the very first delta variant case in Region 1 of Louisiana, which includes the New Orleans city area.

Updated: 3:26 PM CDT Jun 25, 2021

The Precision Medicine Lab at LSU Health New Orleans School of Medicine has reportedly determined the first delta variant case in Region 1 of Louisiana, which includes the New Orleans metropolitan area.Statewide, Louisiana has reported about a dozen cases of the delta variant not including presumptive cases.According to a press release, the Centers for Disease Control and Prevention estimates that this variation is responsible for about 25% of cases in Region 6, that includes Louisiana. The delta version was recently named as a “variant of concern” by the CDC, indicating “there is proof of an increase in transmissibility, more severe illness (e.g., increased deaths or hospitalizations), substantial reduction in neutralization by antibodies produced during previous infection or vaccination, minimized effectiveness of treatments or vaccines, or diagnostic detection failures.”A recent study supposedly showed that the efficiency of both dosages of the Pfizer vaccine in avoiding symptomatic disease caused by the delta variant was 88%.

NEW ORLEANS– The Precision Medicine Lab at LSU Health New Orleans School of Medicine has actually supposedly identified the first delta alternative case in Region 1 of Louisiana, that includes the New Orleans urbane area.Statewide, Louisiana has reported about a dozen cases of the delta variant not consisting of presumptive cases.
According to a press release, the Centers for Disease Control and Prevention approximates that this version is accountable for about 25% of cases in Region 6, that includes Louisiana. The delta version was just recently named as a “variation of issue” by the CDC, suggesting “there is proof of a boost in transmissibility, more severe disease (e.g., increased hospitalizations or deaths), substantial reduction in neutralization by antibodies produced during previous infection or vaccination, reduced efficiency of treatments or vaccines, or diagnostic detection failures.”A current research study reportedly revealed that the efficiency of both doses of the Pfizer vaccine in preventing symptomatic illness triggered by the delta variant was 88%.

Leave a Reply

Your email address will not be published. Required fields are marked *